50
https://pubmed.ncbi.nlm.nih.gov/38117537
Scientists have developed a method to chemically synthesize single glycoforms of the ectodomain of Herpes Simplex Virus-1 glycoprotein D, which exhibited potent in vivo activity in mice, providing a promising platform for studying the functions of gD glycans and developing vaccines against HSV-1 infection.
